baber/WOPTO huggingface dataset:
Patent PT-892020-E (PT)
Title: Use of a copolymer having surfactant structures as dispersing agent and/or grinding aid
Inventor: EGRAZ JEAN-BERNARD
IPC: C09K23/00
Filed: 1998-07-10
Abstract: Use of a copolymer as a dispersion and/or crushing agent for aqueous suspension of mineral materials, namely those materials with hydrophilic or hydrophobic properties; the copolymer comprising: (a) (i) monoacids e.g. (meth)acrylic, (iso)crotonic, and cinnamic; (ii) diacids e.g. fumaric and maleic; (iii) acid anhydrides e.g. maleic anhydride; and (iv) diacid hemiesters such as 1-4C monoesters of maleic acid; (b) optionally at least one unsaturated monomer with a sulphonic group e.g. sodium methallyl-sulphonate or styrene sulphonic acid; or a phosphoric group e.g. propylene glycol (meth)acrylate phosphate; (c) optionally at least one unsaturated monomer without a carboxylic group e.g. (meth)acrylic esters, (meth)acrylonitrile, styrene, (meth)acrylamide; and (d) at least one unsaturated oxyalkyl monomer with terminal hydrophobic chain of general formula: R-Ä-((CH2-CH(R1)-O)m-CH2-CH2-O)n-CH2-CH(R2)-OpÜ< SB>q-R' (where: m, n, p ≤ 100; q is number such that 0 ≤ q x (n + m + p) ≤ 100; R1, R2 = H, methyl, or ethyl; R = polymerisable unsaturated radical belonging to group of esters including (meth)acrylic, crotonic and vinylphthalic, as well as unsaturated urethanes such as (meth)acrylurethane, or allyl-urethane; and R' = hydrophobic radical such as tristyrylphenyl, or 8-30C alkyl, aryl, alkylaryl, arylalkyl; or, when R = urethane, R' = 8C dialkyl, or, preferably, when R = unsaturated polymerisable radical, R' ≥ 22C dialkyl amine; total of (a)+(b)+(c)+(d) = 100 pts.; and suspension has specific viscosity ≤ 25.)
Patent PT-968174-E (PT)
Inventor: FORESTA PIERO
IPC: A61K31/135
Filed: 1998-01-28
Abstract: S(-)-amino-6-fluoro-7-methoxytetraline, a process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock, are disclosed.
Patent PT-958191-E (PT)
Inventor: BRAS PHILIPPE LE
IPC: B65D71/00
Filed: 1998-02-06
Abstract: A carton or carton blank comprising panel interlocking means for securing together a first and a second panel (10, 12) in overlapping relationship, said first panel comprising a locking tab (14) struck from said first panel adjacent a free edge thereof and extending away from the free edge of said first panel, the locking tab having a neck portion (20) hinged at a base thereof to said first panel and terminating in a shoulder portion (22) and wherein said second panel includes an aperture (46) struck from said second panel adjacent a free edge (48) thereof and wherein the aperture is adapted to receive the locking tab such that when the panels are locked together the free edge of said second panel, outboard of said aperture, is located along the locking tab between the base of said neck portion and said shoulder portion.
Patent PT-943735-E (PT)
Inventor: STEHR JURGEN
IPC: E01C23/09
Filed: 1999-02-05
Abstract: On the outer guide frame (6) is arranged an inner guide frame (10), the two guide frames being relatively displaceable to one another. A motor (11) drives at least one milling or driling tool (13), and is arranged on the inner guide frame. As milling or drilling tool, a milling head (13), an earth drill, a tree stump milling head or a milling disk is provided.
Patent PT-991037-E (PT)
Inventor: WILLACH ULRICH
IPC: G07F11/32
Filed: 1999-08-27
Abstract: The dispensing device (10,15) has a number of forwards angled storage shelves for the dispensed goods, stacked one above the other and an electronically controlled manipulator, moved within a free space at the front of the shelves, for removal of the front item from a selected shelf, retained by a stop edge. The manipulator has a manipulator arm brought into a defined position relative to the front of the shelf, with a manipulator finger for moving the item through a removal slot.
Patent PT-1071477-E (PT)
Inventor: BOUGAMONT JEAN-LOUIS
IPC: G02C13/00
Filed: 1999-04-13
Abstract: The invention relates to a packaging and bactericidal treatment device for contact lenses (L), said device being characterized in that it comprises: firstly a housing (1) provided with at least one cavity (10) receiving a support element (11) which has bactericidal action and whose outside face (11a) has curvature matching the curvature of the contact lenses (L); and secondly, at least one lid (2) designed to cover said cavity (10) and whose inside face is provided with at least one socket (20) which is suitable for being engaged in guided manner into said cavity (10), and which receives a wedge element (21) having bactericidal action and whose outside face (21a) has curvature complementary to the curvature of the support element (11) so that it protects and/or decontaminates a contact lens (L) by holding it stationary in said cavity (10) between said support element (11) and said wedge element (21).
Patent PT-1105467-E (PT)
Title: Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
Inventor: VERONESI PAOLO ALBERTO
IPC: A61P37/04
Filed: 1999-05-20
Abstract: A compound of general formula: <?in-line-formulae description="In-line Formulae" end="lead"?>[CH<SUB>3</SUB>O-(CH<SUB>2</SUB>-CH<SUB>2</SUB>-O)<SUB>n</SUB>-CH<SUB>2</SUB>-CH<SUB>2</SUB>]<SUB>x</SUB>-(NH)<SUB>y</SUB>Lysozyme c. (Z)<SUB>m </SUB><?in-line-formulae description="In-line Formulae" end="tail"?> wherein: y is the number of free amino groups of lysine molecules present in the molecule of lysozyme c; x is comprised between 1 and y; n is comprised between 5 and 1000; Z is a pharmaceutically acceptable acid; m is comprised between 1 and y.
Patent PT-1095947-E (PT)
Title: Novel antibacterial compounds
Inventor: HOTODA HITOSHI
IPC: C12R/
Filed: 1999-07-09
Abstract: Compounds of formulae (XI), (XII), (XIV), (XV) and (XVI), as well as amide derivatives of compounds of formula (XIII), described herein, can be obtained from the cultivation products of a strain of micro-organism of the genus Streptomyces. The compounds are useful as medicaments in the treatment and prevention of bacterial infections.
Patent PT-1108435-E (PT)
Title: Preventives or remedies for pancreatitis containing anti-il-6 receptor antibodies as the active ingredient
Inventor: FUNAKOSHI AKIHIRO
IPC: A61K39/395
Filed: 1999-08-23
Abstract: A preventive or therapeutic agent for pancreatitis said agent comprising as an active ingredient an interleukin-6 (IL-6) antagonist such as an antibody directed against IL-6 receptor.
Patent SG-39892-G (SG)
Title: 4,5-dihydro-oxazole derivatives,process for their preparation and their use
IPC: C07D495/04
Filed: 1992-04-11
Abstract: The invention relates to novel derivatives of 4,5-dihydrooxazoles of the formula    <IMAGE>  I  in which A denotes -CH=CH- or -S-, R1, R3 and R4, independently of one another, denote hydrogen or lower alkyl, R2 denotes hydrogen or lower alkoxy, and n denotes 0 or 1, a process for their preparation, and pharmaceutical preparations which contain these compounds. The novel compounds cause blockage of H+/K+ ATPase and can be used as active ingredients in medicaments for treatment and prophylaxis of disorders which are caused by increased gastric secretions.
Patent SG-57592-G (SG)
Title: Shielded header and assembly
IPC: H01R13/658
Filed: 1992-06-02
Abstract: A shielded header serves to establish electrical connection between a cable (18) mounted to a cable connector (12) and a printed circuit board (34) and restricts the emission of electromagnetic energy. The header utilises a dielectric housing (16) with electrical contact pins (14, 14a) mounted therein. The header is efficiently grounded to the cable connector (12) and a chassis (78) carrying the printed circuit board (34) by means of a ground strip (36) attached to the housing lower surface and spring contacts (44) mounted to engage the cable connector (12) inside the housing and the chassis (78) and printed circuit board (34) outside the housing.
Patent IE-810421-L (IE)
Title: Floating-gate storage cell
IPC: G11C11/34
Filed: 1981-02-27
Abstract: 1. Floating-gate storage cell consisting of an n-channel field-effect transistor whose potentially floating gate electrode comprises a first electrode part which, for effecting the tunnel injections of electrons into the gate electrode (1), is coupled capacitively to a writing electrode (4), as well as a second electrode part of polycrystalline silicon which, for effecting the tunnel emissions of electrons from said gate electrode (1) during the erasing operation, is coupled capacitively to an erasing electrode (3), characterized in that moreover said gate electrode (1) is coupled capacitively to a programming electrode (2), that said writing electrode (4) is connected directly in a barrier-free contact to the drain zone (5) of the field-effect transistor, and that the coupling capacitance of said programming electrode (2) towards said gate electrode (1) is greater than that of said writing electrode (4) towards said gate electrode (1) and greater than that of said erasing electode (3) towards said gate electrode (1).
[EP0035160A1]
Patent IE-36312-L (IE)
Title: Aminopyrazolopyrimidines
IPC: C07D487/04
Filed: 1972-04-20
Abstract: 1396302 Growth-promoting &c compositions CIBA-GEIGY AG 26 April 1972 [27 April 1971 2 Feb 1972 3 March 1972 (2)] 11492/71 4788/72 10021/72 and 10022/72 Heading A5B [Also in Division C2] Novel compounds II in which R 1 is C 1-3 alkyl, R 2 is hydrogen or C 1-3 alkyl and X is chloro or NR 3 R 4 (in which R 3 is hydrogen, C 1-3 alkyl, hydroxy C 1-3 alkyl, C 2-4 alkenyl C 1-3 alkoxy C 1-3 alkyl or hydroxy, and R 4 is R 3 other than hydoxy- or R 3 and R 4 form a C 4-6 polymethylene chain optionally interrupted by oxygen) and the S-N oxides and acid addition salts of compounds in which X is NR 3 R 4 are anti-microbial agents. Compounds II in which X is NR 3 R 4 their S-N- oxides and acid addition salts form with a carrier or diluent a pharmaceutical composition which may be administered orally or parenterally; they may be added to animal feedstuffs to promote growth or used to protect organic material from bacterial or nucrobial attack. The compositions may also include 5, 7-dichloro-2-methyl-8-quinolinol; sulphamerazine or sulphafurazole; chloramphenicol or tetracyline; 3, 4', 5-tribromocalicylanilide; halogenated carbonilides, benzoxazoles or benzoxazolones; polychloro-hydroxy-diphenylmethanes; halogen-dihydoxy-diphenyl sulphines; 4, 4'- dichloro-2-hydroxyl-diphenylether or 2, 4, 4'- trichloro-2-hydroxy-diphenylether; bactericidal quaternary compounds, or dithiocarbonic acid derivatives (tetra methyl thiuran disulphide) carriers having favourable pharmacological properties may be used; sulphur as a powder base or zinc stearate as an ointment base.
[GB1396302A]
Patent IE-34224-L (IE)
Title: Tetracycline compounds
IPC: C07C233/00
Filed: 1970-05-25
Abstract: 1,266,083. Tetracycline lactate. FAR EASTERN DETAILERS Ltd. 28 May, 1970 [6 June, 1969], No. 25840/70. Heading C2A. The novel salt tetracycline lactate, comprising a substantially equimolecular combination of tetracycline base and lactic acid, may be prepared from anhydrous materials by reacting tetracycline base in solution in an alcoholic solvent with at least a stoichiometric quantity of pure crystalline lactic acid at room temperature in an inert atmosphere, the resultant solution being concentrated in vacuo in order to promote crystallization of the tetracycline lactate, which is separated from the mother liquor by filtration. Preferably the inert atmosphere is dry nitrogen, the tetracycline base is dried prior to use at 100 to 105 C., the solvent used is anhydrous ethyl alcohol, the resulting solution is concentrated in vacuo to a quarter of its initial volume up to 40 C., and the tetracycline lactate obtained is purified by washing in anhydrous diethyl ether and the pure crystalline lactic acid employed is obtained from racemic lactic acid distilled in vacuo and is used immediately afterwards. Pharmaceutical antibiotic compositions comprise tetracycline lactate and a pharmaceutically acceptable carrier. The compositions may be administered orally in the form of capsules or sachets.
[GB1266083A]
Patent IE-37774-L (IE)
Title: Antirachitic compositions
IPC: C07F9/38
Filed: 1973-06-08
Abstract: 1401548 Pharmaceutical compositions PROCTER & GAMBLE CO 8 June 1973 [8 June 1972 17 May 1973] 27457/73 Heading A5B Pharmaceutical compositions for inhibiting mobilisation of calcium phosphate in animal tissue useful in the treatment of osteoporosis and Paget's disease comprises (1) at least one polyphosphonate selected from the compounds wherein each R is H or CH 2 OH and n is an integer of from 3 to 10 wherein R 1 is H, C 1-20 alkyl, C 2-20 alkenyl, aryl (e.g. phenyl or naphthyl), phenylethenyl, benzyl, halogen (e.g. Cl, Br, or F), hydroxy, amino, substituted amino (e.g. dimethylamino, diethylamino, N-hydroxy-N-ethylamino or acetylamino), -CH 2 COOH, -CH 2 PO 3 H 2 , -CH- (PO 3 H 2 )(OH) or -[CH 2 C(PO 3 H 2 ) 2 ] n -H wherein n is 1 to 15, and R 2 is hydrogen, C 1-4 alkyl, amino, benzyl, halogen, hydroxyl, -CH 2 COOH, -CH 2 PO 3 H 2 , or -CH 2 CH 2 PO 3 H 2 , wherein n is from 3 to 9, wherein each R 3 is hydrogen or C 1-4 alkyl, wherein n is from 2 to 4, wherein X and Y are each hydrogen or hydroxy or a pharmaceutically acceptable salt thereof e.g. an alkali metal (Na or K), alkaline earth metal (Ca or Mg), non-toxic heavy metal (stannous or indium), ammonium or substituteed ammonium (mono-, di- or triethanolamine) salts, and (2) at least one antirachitic compound selected from vitamin D 2 , vitamin D 3 , dihydroxytachysterol 2 , dihydrotachysterol 3 , 25-hydroxydihydrotachysterol 3 , 25-hydroxyergocalciferol, 25-hydroxycholecalciferol, 1α, 25-. dihydroxycholecalciferol, 5, 6-trans-cholecalciferol, 5, 6-trans-25-hydroxycholecalciferol, 24- nor-25-hydroxycholecalciferol, 24-nor-5, 6-trans 25-hydroxycholecalciferol, 21, 25-dihydroxycholecalciferol, 25, 26-dihydroxycholecalciferol, 24, 25-dihydroxycholecalciferol, and 1α- hydroxycholecalciferol. The polyphosphonate is preferably ethane-1-hydroxy-1, 1-diphosphonic acid, dichloromethandiphosphonic acid, tris(phosphonomethyl)amine, methanecyclohexylhydroxydiphosphonic acid 3, 3, 4, 4, 5, 5- hexafluoro-1, 2-diphosphonocyclopent-1-ene, cyclic tetraphosphonic acid, ethene-1, 2-dicarboxy-1-phosphonic acid or ethane-1, 2-dicarboxy-1, 2-diphosphonic acid. The compositions may be administered orally or parenterally in the form of solutions, elixiers, capsules, tablets, or pills.
[GB1401548A]
Patent FI-813885-L (FI)
Inventor: BITTERA MIKLOS VON
IPC: A61K9/12
Filed: 1981-12-03
Abstract: 1. Claims for the contracting states : BE, CH, LI, DE, FR, GB, IT, NL, SE Antimycotic agents which have relatively good release of active compounds and contain azole derivatives and customary formulation auxiliaries, characterised in that they contain 2-10% by weight of a spreading agent from the group consisting of isopropyl myristate, isopropyl palmitate, isopropyl stearate, caprylates/caproates of saturated fatty alcohols having the chain length of C12 to C18 , wax-like fatty acid esters, such as synthesized duck uropygial gland fat, silicone oils, isopropyl myristate/isorpopyl palmitate/isopropyl stearate mixture, coconut fatty acid isopropyl ester, 1-8% by weight of a solubilising agent and, as a film-forming agent, a quick-drying polyvinylpyrrolidone, a terpolymer of 30% by weight of vinylpyrrolidone, 40% by weight of vinyl acetate and 30% by weight of vinyl propionate, or a vinylpyrrolidone/vinyl acetate copolymer. 1. Claims for the contracting state : AT Process for the production of antimycotics based on azole derivative active compounds and costumary formulation auxiliaries, characterised in that the active compounds and the formulation auxiliaries are formulated together with 2 to 10% by weight of isopropyl myristate, isopropylpalmitate, isopropyl stearate, caprylates/caproates of saturated fatty alcohols having the chain length of C12 to C18 , waxy fatty acid esters, such as synthesized duck uropygial gland fat, silicone oils, isopropyl myristate/isopropyl palmitate/isopropyl stearate mixture or cocount fatty acid isopropylester as spreading agents, 1 to 8% by weight of solubilising agents, based in each case on the total weight, and a quick drying polyvinylpyrrolidone, a terpolymer of vinylpyrrolidone/vinyl acetate/vinyl propionate in a ratio by weight of 30:40:30, or a vinylpyrrolidone/vinylacetate copolymer as the film-forming agent.
Patent FI-830492-L (FI)
Inventor: WADE DAVID WILLIAM
IPC: B01D37/02
Filed: 1983-02-14
Abstract: An organic suspension, such as sewage sludge, is conditioned by adding a conditioner and then filtering the suspension through a filter element to form a filter cake on the element. Improved dryness properties of the cake are obtained by using as conditioner during the formation of at least the first half (by weight solids), but not all, of the cake a high molecular weight polyelectrolyte conditioner and by using as conditioner during the formation of the remainder of the cake an inorganic conditioner or a low molecular weight polyelectrolyte conditioner.
Patent IE-41068-L (IE)
Title: Electrochemical cell
IPC: C25C1/00
Filed: 1975-05-19
Abstract: 1497542 Electrolytic cell with particulate electrode PAREL SA 20 May 1975 [30 May 1974] 24077/74 Heading C7B At least two electro-chemical cells are separated by an impermeable bi-polar member, each cell having at least one particulate and one counter electrode, the bi-polar member providing electrical connection between the particulate electrode of one cell and the counter electrode of the next cell and at least part of the bi-polar member being in electrical contact with and acting as current feeder for the particulate electrode. Each cell may contain a fluid-permeable or ion-selective membrane separating the particles from the counter electrode. A series of e.g. up to 100 cells may be arranged in a "filter-press" construction. The bi-polar member may be planar and one face may act as the counterelectrode. The ratio of the area of the particlecontacting side to the electrically active area of the other side of the member may be 1:2 to 1:10. The member may be of Ti with optionally fins or a mesh of rods or wire on the anodic side coated with an electrocatalytic material, and being insulated where desired by a TiO 2 coating. The cathodic side may be partly covered by TiO 2 , paint or plastics insulation. The member may be bimetallic with a Ti anodic side as above and a Cu cathode side, or may comprise an insulating sheet with the said mesh on its anodic side and having a Cu strip let into its cathode side flush with the sheet. The cell may be vertical but preferably at least the diaphragm is inclined away from the vertical and overlies the particles to produce suitable particle circulation. The particles may be fluidized and recirculated via a classifier which removes any which are too large after electro-deposition thereon. Both anolyte and catholyte may be recirculated separately or together. Each cell compartment may contain a fluidized electrode. The recovery of Cu from a CuSO 4 solution with production of O 2 and deposition on Cu particles of 200-800Á is specified.
[GB1497542A]
Patent IE-34716-L (IE)
Title: Pourable margarine
IPC: A23D7/005
Filed: 1970-11-11
Abstract: 1333938 Pourable margarine MARGARINBOLAGET AB 10 Nov 1970 [14 Nov 1969] 53334/70 Heading C5C A pourable margarine is stabilized by bubbles of an inert gas amounting to 0À5 to 20% by volume. The preferred gas is nitrogen, but air, helium or CO 2 may be used. The oil phase of the margarine may comprise a major proportion of edible oil pourable at temperatures below 25 C., safflower, sunflower, soybean, wheat germ, grapeseed, poppyseed, tobacco seed, rye, walnut or corn oil, and a minor proportion of a fully hydrogenated oil or fat, e.g. hydrogenated rapeseed oil, mustard seed oil, groundnut oil, soybean oil, sunflower oil, lard, tallow, palm oil or cottonseed oil. A monoglyceride, diglyceride or phosphatide emulsifier may also be present. The margarine may be made by emulsifying the aqueous phase into the fat phase, cooling, dispersing the inert gas into the cooled emulsion, filling into receptacles, and storing at 5 to 18 C. In the examples, the aqueous phase comprises skimmed milk, salt and water and the fat phase contains also colouring agents, vitamins and flavours.
[GB1333938A]
Patent IE-901451-L (IE)
Title: Protective arrangement for telecommunications line interface¹circuit
IPC: H01H85/00
Filed: 1990-04-24
Abstract: A circuit protection device designed to protect a pair of electrical circuits by fracturing at such time as an overcurrent condition has occurred in a first of the circuits, this novel device comprising a substantially flat substrate of non-conductive, frangible material upon which a resistive component and a fuse conductor reside in an adjacent relationship on a common surface. The resistive component is part of a first circuit, and the fuse conductor is part of a second circuit. The resistive component, at the time of an overcurrent therethrough, becomes hot and causes a heating of the near surface of the frangible substrate. The frangible substrate, as a result of the uneven heating of its opposite surface, elongating and then fracturing, the fracturing of the frangible substrate thereby bringing about a fracturing of the resistive component as well as a fracturing of the fuse conductor, thus to effect an interruption of the first circuit as well as a substantially simultaneous interruption of the second circuit. This novel device is admirably suited for protecting a subscriber line interface circuit.
[EP0395231A2]
Patent IE-871567-L (IE)
Title: Method for treating depression
IPC: A61K31/135
Filed: 1987-06-12
Abstract: D-fenfluramine is administered to a human patient having seasonal depression or other forms of bipolar depression in order to alleviate or cure the depression. The invention provides the respective medicaments.
Patent IE-851621-L (IE)
Title: Shoring system for trenches
IPC: E02D17/08
Filed: 1985-06-27
Abstract: A cribbing device for trenches which includes a pair of opposing supports spaced apart by a spreader, each support having a plurality of guide profiles and a crosspiece. The crosspiece is disposed transversely to the longitudinal axis of the trench, and the guide profiles are arranged adjacent each other on said crosspiece. The guide profiles include a plurality of legs disposed vertically and extending outward from the crosspiece, and a plurality of flanges disposed vertically and secured to the legs at the ends of the legs opposite the crosspiece. The flanges project beyond both sides of the legs. A plurality of cribbing boards each having a guide bar which supports a guide head is provided. The guide head is in the form of a slotted hollow box section and extends vertically beyond the board at its vertical face side. The width of each guide profile flange is slightly smaller than the inside width of the guide heads. The slot of the guide heads corresponds to the legs of the guide profiles, and the inside spacings between the legs of the adjacent guide profiles is slightly larger than the total width of the guide heads. The boards may, therefore, be guided and supported by the supports by engaging the guide heads of the boards with the guide profiles of the supports thereby permitting the boards to be passed by each other on parallel planes and to be supported by the supports in a form-locked manner.